Publications by authors named "J Salazar-Fraile"

Background: Substantial evidence supports the existence of neurocognitive endophenotypes in bipolar disorder (BD), but very few longitudinal studies have included unaffected relatives. In a 5-year, follow-up, family study, we have recently suggested that deficits in manual motor speed and visual memory could be endophenotype candidates for BD. We aimed to explore whether this also applies to processing speed.

View Article and Find Full Text PDF

Schizophrenia is a chronic mental condition presenting a wide range of symptoms. Although it has a low prevalence compared to other mental conditions, it has a negative impact on social and occupational functions. This study aimed to assess the appropriateness of antipsychotic medications administered to schizophrenic patients and describe current treatment patterns for schizophrenia.

View Article and Find Full Text PDF

Factors relating to the interpersonal relationship between the patient and their physician and social environment are important components, which contribute to their response to treatment for major depressive disorder. This study aimed to assess the influence of optimism, perfectionism, therapeutic alliance, empathy, social support, and adherence to medication regimen in the response to antidepressant treatments in the context of normal primary care clinical practice. We conducted a prospective study in which 24 primary care physicians administered sertraline or escitalopram to 89 patients diagnosed with major depressive disorder.

View Article and Find Full Text PDF
Article Synopsis
  • People with schizophrenia and severe mental disorders face higher mortality rates, largely due to cardiovascular diseases and cancer, which are linked to their condition and the use of antipsychotic medications.
  • A study in an outpatient mental health clinic found that nearly half of the 130 participants had metabolic syndrome, with obesity being the most common factor, while the overall cardiovascular risk score was moderate.
  • The findings highlight a significant prevalence of metabolic syndrome and cardiovascular risk in those treated with long-acting injectable antipsychotics, pointing to the need for both behavioral and pharmacological strategies to manage these health issues.
View Article and Find Full Text PDF